Preventing type 2 diabetes: public health implications for women with a history of gestational diabetes mellitus

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 4, 2009, Pages 365.e1-365.e8

  England, Lucinda J ^a   Dietz, Patricia M ^a   Njoroge, Terry ^a   Callaghan, William M ^a   Bruce, Carol ^a   Buus, Rebecca M ^a   Williamson, David F ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

diabetes gestational diabetes; postpartum screening; prevention

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; METFORMIN; PIOGLITAZONE; RAMIPRIL; ROSIGLITAZONE; TETRAHYDROLIPSTATIN; TROGLITAZONE;

ARTICLE; CLINICAL TRIAL; DIET; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT REFERRAL; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PUBLIC HEALTH; PUERPERIUM; SCREENING TEST; WEIGHT REDUCTION;

EID: 62749200423     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.06.031     Document Type: Article

References (68)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Yach D., Stuckler D., and Brownell K.D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12 (2006) 62-66
3. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
4. Gillies C.L., Abrams K.R., Lambert P.C., et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334 (2007) 299
5. Oldroyd J.C., Unwin N.C., White M., Mathers J.C., and Alberti K.G. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract 72 (2006) 117-127
6. Nathan D.M., Davidson M.B., DeFronzo R.A., et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30 (2007) 753-759
7. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072-2077
8. Buchanan T.A., Xiang A.H., Peters R.K., et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51 (2002) 2796-2803
9. Buchanan T.A. Pancreatic beta-cell loss and preservation in type 2 diabetes. Clin Ther 25 Suppl 2 (2003) B32-B46
10. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
11. Pan X.R., Li G.W., Hu Y.H., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20 (1997) 537-544
12. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A.D., and Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49 (2006) 289-297
13. Xiang A.H., Peters R.K., Kjos S.L., et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55 (2006) 517-522
14. Torgerson J.S., Hauptman J., Boldrin M.N., and Sjostrom L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27 (2004) 155-161
15. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
16. Buchanan T.A., and Xiang A.H. Gestational diabetes mellitus. J Clin Invest 115 (2005) 485-491
17. Engelgau M.M., Colagiuri S., Ramachandran A., Borch-Johnsen K., and Narayan K.M. Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions. Diabetes Technol Ther 6 (2004) 874-882
18. US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: Recommendations and rationale. Ann Intern Med 138 (2003) 212-214
19. Hunt K.J., and Schuller K.L. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 34 (2007) 173-199
20. Kaaja R.J., and Greer I.A. Manifestations of chronic disease during pregnancy. JAMA 294 (2005) 2751-2757
21. Buchanan T.A., and Xiang A.H. Gestational diabetes mellitus. J Clin Invest 115 (2005) 485-491
22. Russell M.A., Phipps M.G., Olson C.L., Welch H.G., and Carpenter M.W. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 108 (2006) 1456-1462
23. Kim C., Tabaei B.P., Burke R., et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 96 (2006) 1643-1648
24. Smirnakis K.V., Chasan-Taber L., Wolf M., Markenson G., Ecker J.L., and Thadhani R. Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol 106 (2005) 1297-1303
25. Schaefer-Graf U.M., Buchanan T.A., Xiang A.H., Peters R.K., and Kjos S.L. Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 186 (2002) 751-756
26. Conway D.L., and Langer O. Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 181 (1999) 610-614
27. Albareda M. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26 (2003) 1199-1205
28. Lee A.J., Hiscock R.J., Wein P., Walker S.P., and Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30 (2007) 878-883
29. Kim C., Newton K.M., and Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25 (2002) 1862-1868
30. Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Health Interview Statistics. http://www.cdc.gov/diabetes/statistics/incidence/fig2.htm Accessed Sept. 4, 2007
31. Oldfield M.D., Donley P., Walwyn L., Scudamore I., and Gregory R. Long term prognosis of women with gestational diabetes in a multiethnic population. Postgrad Med J 83 (2007) 426-430
32. Kousta E., Lawrence N.J., Godsland I.F., et al. Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf) 59 (2003) 289-297
33. Kousta E., Efstathiadou Z., Lawrence N.J., et al. The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes. Diabetologia 49 (2006) 36-40
34. Kjos S.L., Peters R.K., Xiang A., Henry O.A., Montoro M., and Buchanan T.A. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 44 (1995) 586-591
35. Ben-Haroush A., Yogev Y., and Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21 (2004) 103-113
36. Hanson U. Increased molar proinsulin-to-insulin ratio in women with previous gestational diabetes does not predict later impairment of glucose tolerance. Diabetes Care 19 (1996) 17-20
37. Aberg A.E. Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand 81 (2002) 11-16
38. Benjamin E., Winters D., Mayfield J., and Gohdes D. Diabetes in pregnancy in Zuni Indian women. Prevalence and subsequent development of clinical diabetes after gestational diabetes. Diabetes Care 16 (1993) 1231-1235
39. O'Sullivan J.B. Diabetes mellitus after GDM. Diabetes 40 Suppl 2 (1991) 131-135
40. Damm P. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 167 (1992) 607-616
41. Santaguida P.L., Balion C., Hunt D., et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess (Summ) 128 (2005) 1-11
42. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Gestational diabetes. Obstet Gynecol 98 (2001) 525-538
43. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 27 Suppl 1 (2004) S88-S90
44. Standards of medical care in diabetes-2007. Diabetes Care 30 Suppl 1 (2007) S4-S41
45. Metzger B.E., Buchanan T.A., Coustan D.R., et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30 Suppl 2 (2007) S251-S260
46. Buchanan T.A. (How) can we prevent type 2 diabetes?. Diabetes 56 (2007) 1502-1507
47. Xiang A.H., Wang C., Peters R.K., Trigo E., Kjos S.L., and Buchanan T.A. Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55 (2006) 1074-1079
48. Festa A., Williams K., D'Agostino Jr. R., Wagenknecht L.E., and Haffner S.M. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55 (2006) 1114-1120
49. Goldfine A.B., Bouche C., Parker R.A., et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. PNAS 100 (2003) 2724-2729
50. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 357: Primary and preventive care: periodic assessments. Obstet Gynecol 108 (2006) 1615-1622
51. Gabbe S.G., Gregory R.P., Power M.L., Williams S.B., and Schulkin J. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 103 (2004) 1229-1234
52. Dinh D.T., Musser J., and Bayliss P.M. Does postpartum diabetic testing occur in gestational diabetes?. Prim Care Update 10 (2003) 182-185
53. Greenberg L.R. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 86 (1995) 97-101
54. Dacus J.V., Meyer N.L., Muram D., Stilson R., Phipps P., and Sibai B.M. Gestational diabetes: postpartum glucose tolerance testing. Am J Obstet Gynecol 171 (1994) 927-931
55. Kaufmann R.C., Smith T., Bochantin T., Khardori R., Evans M.S., and Steahly L. Failure to obtain follow-up testing for gestational diabetic patients in a rural population. Obstet Gynecol 93 5 Pt 1 (1999) 734-737
56. Ratner R.E. Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care 30 Suppl 2 (2007) S242-S245
57. Gerstein H.C., Yusuf S., Bosch J., et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368 (2006) 1096-1105
58. Schwartz A.V. Thiazolidinediones: new evidence of bone loss. J Clin Endocrinol Metab 92 (2007) 1232-1234
59. Schwartz A.V. Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?. Diabetes Care 30 (2007) 1670-1671
60. Schwartz A.V. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 91 (2006) 3349-3354
61. Solomon D.H. Cardiovascular risk and the thiazolidinediones: deja vu all over again?. JAMA 298 (2007) 1216-1218
62. Haffner S.M. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39 (1990) 283-288
63. Polley B.A., Wing R.R., and Sims C.J. Randomized controlled trial to prevent excessive weight gain in pregnant women. Int J Obes Relat Metab Disord 26 (2002) 1494-1502
64. Leermakers E.A., Anglin K., and Wing R.R. Reducing postpartum weight retention through a correspondence intervention. Int J Obes Relat Metab Disord 22 (1998) 1103-1109
65. O'Toole M.L., Sawicki M.A., and Artal R. Structured diet and physical activity prevent postpartum weight retention. J Womens Health 12 (2003) 991-998
66. Gabbe S., Hill L., Schmidt L., and Schulkin J. Management of diabetes by obstetrician-gynecologists. Obstet Gynecol 91 5 Pt 1 (1998) 643-647
67. Cheung N.W., and Byth K. Population health significance of gestational diabetes. Diabetes Care 26 (2003) 2005-2009
68. Kim C., Herman W.H., and Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 30 (2007) 1102-1106